The management of obesity remains a major challenge. Dietary therapy often fails, whereas
bariatric surgery, although successful, is demanding and applicable to a limited number of …

Obesity is a major correlate of cardiovascular disease. Weight loss improves cardiovascular
risk factors and has the potential to improve outcomes. Two drugs, phentermine plus …

Obesity is an epidemic and a public health threat. Medical weight management remains one
of the options for the treatment of excess weight and recent advances have revolutionized …

Introduction Pharmacotherapy is a useful adjunct when patients with obesity are unable to
achieve adequate benefit from lifestyle interventions. Areas covered This review covers the …

Obesity is a severe worldwide epidemic. Obesity comorbidities, such as type 2 diabetes
mellitus, hypertension, and atherosclerosis, are costly for patients and governments. The …

Abstract Purpose of Review To highlight the added benefits of approved and upcoming,
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …

In many industrialized nations, obesity is now considered an epidemic, resulting in
accelerated morbidity and mortality. Obesity is associated with an increased risk of coronary …

Obesity is a significant health problem worldwide and is associated with a number of co-
morbidities including type 2 diabetes mellitus, hypertension, dyslipidemia, obstructive sleep …

Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

Obesity is one of the greatest public health challenges of the twenty-first century. The World
Health Organization (WHO) reports that in 2005 approximately 1.6 billion adults were …